BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

December 22, 2016 12:44 AM UTC

In vitro studies identified an phenyldiazole-based inhibitor of DDX39B ATPase activity that could help treat HSV and other Herpesviridae viral infections. In silico screening of a small molecule libra...

BCIQ Company Profiles

Cancer Research UK

BCIQ Target Profiles

DEAD box helicase 39B (DDX39B)